“[t]he combination of tumor-associated neu5gc and [our] circulating anti-neu5gc autoantibodies promotes tumor growth, by inducing weak inflammation, causing infiltration of inflammatory cells and [enhancing] angiogenesis [enhanced blood flow to the tumor].”